课题基金 / 基金详情

Genes and Genetic Models in Motor Neuron Disorders

Genes and Genetic Models in Motor Neuron Disorders
运动神经元疾病的基因和遗传模型
批准号:
7100132
负责人:
TEEPU SIDDIQUE
金额:
$33.54万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2008-06-30

项目摘要

项目成果

TEEPU SIDDIQUE的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):家族性肌萎缩侧索硬化症(FALS),‘纯’遗传性痉挛麻痹(HSP)和原发性侧索硬化症(PLS)是由运动神经元变性引起的遗传异质性疾病。这些疾病要么同时影响上运动神经元和下运动神经元(FAL),要么主要影响上运动神经元(HSP和PLS)。我的实验室的长期目标是确定这些疾病的发病机制中的遗传因素。这一目标的成功将导致制定基于疾病机制的干预措施,以预防、推迟和治疗这些及相关的疾病。我们现在计划在过去五年中完成的工作基础上再接再厉,作为计划项目(NS 21442)的一部分。我们完成了所有的特定目标,从而我们在染色体2q33上鉴定了导致隐性FALS(Als2)和隐性幼年综合征(JPLS1)的ALSIN基因,研究了导致HSP(SPG5)的SPASTIN突变,并在染色体9q21-q22上发现了显性ALS(在X染色体上)和ALS/痴呆的新基因座。我们将进一步扩大我们在隐性ALS和隐性HSP中的基因发现工作,开发FAL、JPLs和HSP的遗传模型,并询问致病基因的蛋白-蛋白质相互作用产物,以追踪它们的信号通路。我们计划通过三个主要的具体目标来实现这些目标:(1)确定染色体15q15-q21上更常见的隐性FALS(ALS5)和染色体8q上的常见隐性HSP(SPG5A)的基因。(2)建立JPLS和ALS表型的alsin和HSP表型(SPG4)的spastin的遗传模型。(3)确定alsin的蛋白质相互作用。在前一时期,我们缩小了ALS5和SPG5A的基因座。我们将使用高通量测序和生物信息学支持来识别这些基因,就像我们成功地识别als2基因一样。我们将制作alsin和spastin的基因敲除模型,以研究这些疾病的病理和发病机制。最后,alsin和随后的spastin的相互作用的伙伴蛋白将被双杂交系统和免疫沉淀所询问。相互作用将通过双标记共聚焦显微镜和FRET分析得到证实。
英文摘要
DESCRIPTION (provided by applicant): Familial amyotrophic lateral sclerosis (FALS), 'pure' hereditary spastic paraparesis (HSP) and primary lateral sclerosis (PLS) are genetically heterogeneous disorders caused by motor neuron degeneration. These disorders either affect, both the upper and lower motor neurons (FALS), or primarily the upper motor neuron (HSP and PLS). The long-term goal of my laboratory is to identify the genetic contribution to the pathogenesis of these disorders. Success in this goal will lead to the formulation of interventions based on disease mechanisms to prevent, postpone and treat these and related disorders. We now plan to build on the work we accomplished in the last five years as part of a program project (NS 21442). We fulfilled all the Specific Aims such that we identified the ALSIN gene, that cause both recessive FALS (ALS2) and recessive juvenile PLS (JPLS1), on chromosome 2q33, studied mutations in SPASTIN that cause HSP (SPG5), and identified new loci for dominant ALS (on the X-chromosome) and ALS/dementia on chromosome 9q21-q22. We will further expand our gene discovery effort in recessive ALS and recessive HSP develop genetic models of FALS, JPLS, and HSP, and interrogate the products of causative genes for their protein-protein interactions to trace their signaling pathways. We plan to accomplish these goals by three main Specific Aims (1) Identify the genes for a more common form of recessive FALS (ALS5) on chromosome 15q15-q21 and a common form of recessive HSP (SPG5A) on chromosome 8q. (2) Develop genetic models of alsin for the JPLS and ALS phenotypes and of spastin for the HSP phenotype (SPG4). (3) Identify protein interactions of alsin. In the previous period we narrowed the loci for ALS5 and SPG5A. We will use high throughput sequencing and bioinformatic support to identify these genes, as we successfully did the case of the ALS2 gene. We will make knockout models for alsin and spastin, to study the pathology and pathogenesis of these disorders. Finally, the interacting partner proteins of alsin and subsequently of spastin will be interrogated by the two-hybrid systems and immunoprecipitation. Interaction will be confirmed by dual labeled confocal microscopy and FRET analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel innate immunity risk factor for amyotrophic lateral sclerosis
A novel innate immunity risk factor for amyotrophic lateral sclerosis
Investigation of ALS caused by mutant CHCHD10
Investigation of ALS caused by mutant CHCHD10
海外基金